The Department of Pharmacy of Queen Mary Hospital (QMH) provides quality, patient-centred and holistic pharmaceutical care to the public in Hong Kong. Queen Mary Hospital is a teaching hospital founded in 1937 with more than 1,400 beds. Affiliated with the University of Hong Kong, the Department of Pharmacy provides professional training and education to medical, nursing and pharmacy students.

The Department of Pharmacy provides 24-hour-a-day, 7-day-a-week pharmaceutical services to all inpatients and outpatients, including patients from Specialist Outpatient Clinics and Accident & Emergency Department. The Department of Pharmacy is providing pharmaceutical care to approximately 30,000 outpatients and 8,000 inpatients per month. In addition to medication management, the Department of Pharmacy is clinically oriented which provides a great variety of Clinical Pharmacy services. Queen Mary Hospital was also accredited with an "Excellence" Achievement on medication safety by the Australian Council on Healthcare Standards (ACHS) in 2010.

The Department of Pharmacy of Queen Mary Hospital is the pioneering site for many Hospital Authority’s initiatives including: Medication Incident Reporting Programme, Drug Information Kiosk, 24-hour Pharmaceutical Services, Medication Reconciliation Service, Clinical Trial Service and Clinical Pharmacy Service.

Our Vision

To provide a safe, quality and patient-centred pharmaceutical care to people in Hong Kong

Our Mission

To exert professional pharmaceutical services to patients through teamwork, innovative services and collaboration with other healthcare professionals

Our Service

General Service
  • Provide 24-hour pharmacy services to inpatients, outpatients including patients from Specialist Outpatient Clinics and Accident & Emergency Department
Clinical Pharmacy Services
  • Services cover Adult Intensive Care Unit (AICU), Paediatric Intensive Care Unit (PICU), Neonatal Intensive Care Unit (NICU), medical and surgical admission wards, Haematology and Oncology wards
  • Attend ward rounds with physicians and other healthcare professionals
  • Provide medication review and medication reconciliation services
  • Enhance patient adherence by discharge counseling, e.g. patients newly prescribed with CAPD at Renal ward
  • Provide patient counseling and subsequent follow-up for patients recruited under Integrated Care and Discharge Support for Elderly Patients (ICDS)
Drug Information Service
  • The Department of Pharmacy has implemented a Drug Information Service since August 1995, targeting doctors, nurses, other allied health professionals, patients and the public
  • Promote the safe, efficient and cost-effective use of medications for patients by the provision of update and accurate drug information and advice
  • Provide update drug information by the publication of drug bulletins
  • Manage all new drug applications and provide information support and advices on the drug applications
  • Periodically revise and update the Hospital Drug Formulary
Concordance Service
  • Provide pharmaceutical care to outpatients and discharged patients by Clinical Pharmacists with aims to solve their drug-related problems, improve therapeutic outcomes and enhance self-management of patients
  • Target patients with polypharmacy and/or poor drug adherence. Clinical Pharmacists monitor the therapeutic outcomes of these patients
Pharmacist-led Anticoagulant Clinic
  • Pharmacist-led Anticoagulant Clinic has been implemented in Queen Mary Hospital since 2009
  • Provide personalised pharmaceutical care including INR monitoring, dosage adjustment, therapeutic monitoring and patient counselling with prescribing authority according to protocols to patients on anticoagulants
Clinical Trials Pharmacy
  • Actively participate in the management of all investigational drugs with compliance to the Good Clinical Practice of The International Council for Harmonisation (ICH-GCP)
  • Collaborate with the Clinical Trials Centre, the University of Hong Kong to provide pharmaceutical services and advices for conducting clinical trials of new drugs in Hong Kong
  • Accredited by the National Medical Products Administration (NMPA) in 2012